Klotho

Klotho (also known as Alpha-Klotho, KL, Soluble Klotho, Klotho protein fragment) is a prominently researched experimental compound classified strictly within the Anti-Aging Protein framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it klotho is a type-I transmembrane aging-suppressor protein expressed primarily in kidney tubular cells and brain choroid plexus. Cleaved extracellularly to generate soluble Klotho, which circulates systemically and acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. Also directly inhibits IGF-1 and Wnt signaling pathways that drive cellular senescence. Circulating Klotho declines dramatically with age. A single administration of soluble Klotho protein restored cognitive function in aged mice to levels of young adults within 2 weeks. with a documented biological half-life of roughly 8 hours, In preclinical investigative trials and independent academic studies, researchers utilizing Klotho have documented significant, quantifiable biological outcomes, primarily focusing on cognitive aging reversal, kidney protection, cardiovascular protection, longevity, fgf23 regulation. Typical research protocols investigate administering 10 to 30mcg via iv pathways single dose or pulsed quarterly (mouse/nhp study protocol). However, it is critically important to understand that while Klotho demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.